明胶
材料科学
生物相容性
再生(生物学)
骨愈合
生物医学工程
双膦酸盐
骨组织
骨质疏松症
化学
外科
医学
冶金
生物化学
病理
生物
细胞生物学
作者
Jia Li,Jun Wu,Feihong Liu,Xiang Li,Peng Yu,Haobo Pan,Kwk Yeung,Tak Man Wong
出处
期刊:ACS Biomaterials Science & Engineering
[American Chemical Society]
日期:2023-11-09
卷期号:9 (12): 6849-6859
被引量:4
标识
DOI:10.1021/acsbiomaterials.3c01080
摘要
The development of magnesium-derived biomaterials is one of the most promising research in bone tissue engineering, and related strategies have been extensively used for tendon, skull, cartilage, and bone regeneration. Also, alendronate, a well-recognized drug for osteoporosis treatment, has recently attracted a great deal of attention for bone repair. However, rapid corrosion in vivo of Mg2+ and low systemic bioavailability of alendronate are the main limitations hampering their full exploitation. In this work, by means of physical and chemical cross-linking conjugating magnesium-metal-organic frameworks (Mg-MOFs) and bone-targeting alendronate to biocompatible gelatin scaffolds, a facile method is developed for the preparation of organic/inorganic nanocomposite gel scaffolds. The results affirmed that the nanocomposite gel scaffolds possessed excellent biocompatibility, continuous slow release of Mg2+ and alendronate, strong bone affinity, and bone regeneration. It is noteworthy that the continuous slow release of Mg2+ and alendronate could induce the macrophage switch to the M2 phenotype and promote osteogenic differentiation in the early stage, resulting in improved bone regeneration during implanting the scaffolds into the distal femoral. In summary, Mg-MOFs-loaded alendronate-modified gelatin gel scaffolds have been developed, exhibiting great potential for bone regenerative.
科研通智能强力驱动
Strongly Powered by AbleSci AI